Chronic recurrent multifocal osteomyelitis (CRMO) - advancing the diagnosis

Area of Science:

• Pediatric rheumatology
• Pediatric orthopedics
• Pediatric bone diseases

Background:

• Chronic recurrent multifocal osteomyelitis (CRMO) is an underdiagnosed inflammatory bone condition primarily affecting children and adolescents.
• Delayed diagnosis of CRMO can lead to prolonged antibiotic treatments, unnecessary radiation exposure, and invasive surgical procedures like bone biopsies.
• Early identification of CRMO is crucial to prevent long-term complications and improve patient outcomes.

Purpose of the Study:

• To analyze the clinical features and diagnostic timelines for pediatric CRMO patients.
• To develop and evaluate diagnostic criteria for CRMO to potentially reduce the need for invasive procedures.
• To assess the impact of increased awareness on CRMO diagnosis rates.

Main Methods:

• Retrospective review of 41 pediatric patients diagnosed with CRMO between 2005 and 2012.
• Analysis of symptom onset, time to diagnosis, and diagnostic methods used.
• Development and retrospective application of novel diagnostic criteria for CRMO.

Main Results:

• A median diagnosis time of 15 months was observed for CRMO patients.
• A statistically significant decreasing trend in diagnosis time was noted over the study period.
• The developed diagnostic criteria could have potentially diagnosed 83% of the cohort without requiring a biopsy.

Conclusions:

• Increased awareness and knowledge of CRMO among healthcare professionals may expedite diagnosis.
• The proposed Bristol diagnostic criteria, when applied by experienced clinicians, may reduce the necessity of bone biopsies in select CRMO cases.
• Refining diagnostic approaches for CRMO can improve patient management and reduce healthcare burdens.